A growing cohort of biohackers, including Dave Asprey, are using low-dose nicotine pouches to improve their cognitive performance and brain health. The Post spoke to two neurologists to find out how the science behind the drug's image makeover stacks up.
“Are you over the age of 21?” the perky representative asked as she handed me two tins of ALP nicotine pouches.
We were at Dave Asprey’s Beyond Biohacking Conference, where attendees crowded around the booth to get their hands on the brand’s fruity a... [7189 chars]